Antibiotic Selection for Sepsis in Dialysis Patients

Initial Antibiotic Administration

Administer full loading doses immediately regardless of renal function, as loading doses are not affected by renal impairment and are essential to rapidly achieve therapeutic drug levels in critically ill septic patients with expanded extracellular volume from fluid resuscitation 1, 2
Obtain blood cultures before initiating antibiotics, but never delay antibiotic administration beyond 1 hour of sepsis recognition, as each hour of delay significantly increases mortality 1, 3
The choice of empiric antibiotic should be based on suspected source, local resistance patterns, and patient-specific risk factors for multidrug-resistant organisms 1

Administer a loading dose of 25-30 mg/kg of vancomycin (based on actual body weight) regardless of renal function to rapidly achieve therapeutic levels 1, 2
Target trough concentrations of 15-20 mg/L with pre-dose monitoring for vancomycin 1, 2
Do not use standard once-daily dosing of aminoglycosides in patients with severe renal dysfunction or on dialysis, as the drug will not clear within several days 1, 2
For dialysis patients requiring aminoglycosides, administer 12-15 mg/kg (gentamicin equivalent) two to three times per week, not daily 4
Give doses after hemodialysis on dialysis days for aminoglycosides and other antibiotics significantly removed by dialysis 4

Use continuous renal replacement therapy (CRRT) rather than intermittent hemodialysis in hemodynamically unstable septic patients, as CRRT facilitates fluid balance management during aggressive resuscitation and causes less hemodynamic instability 5
Maintain mean arterial pressure ≥65 mmHg with norepinephrine as first-line vasopressor 5
Never reduce or omit loading doses due to renal dysfunction—loading doses are determined by volume of distribution, not renal function, and are essential for rapid therapeutic levels 1, 2
Avoid underdosing beta-lactams by using extended infusions (2-4 hours) rather than standard 30-minute boluses, as this optimizes pharmacodynamic targets and improves outcomes in severe sepsis 1, 2

For beta-lactam antibiotics like meropenem, the critical pharmacodynamic parameter is time above MIC (T>MIC), with optimal outcomes in severe sepsis requiring 100% T>MIC, as recommended by the European Society of Clinical Microbiology and Infectious Diseases 6
The elimination half-life during CVVHD ranges from 2.5-4.8 hours, substantially shorter than the 13.7 hours seen in anuric patients not receiving renal replacement therapy, according to the American College of Clinical Pharmacy 6

In septic shock with hemodynamic instability, CVVHD is preferred over intermittent hemodialysis as it facilitates fluid balance management during aggressive resuscitation, as suggested by the Society of Critical Care Medicine 7
CVVHD is also preferred due to its ability to remove meropenem in a predictable and less variable manner compared to intermittent hemodialysis, as stated by the European Renal Association 8